Effects of human parvovirus B19 on expression of defensins and toll-like receptors

Chinese Journal of Physiology

Volumn 54, Issue 5, 2011, Pages 367-376

  Hsu, Gwo Jong ^a   Tzang, Bor Show ^b,c   Tsai, Chun Chou ^b   Chiu, Chun Ching ^b,d   Huang, Chih Yang ^e,f   Hsu, Tsai Ching ^b,f  

^a CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d Department of Medical Intensive Care Unit Chunghua Christian Hospital ^*  (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f ASIA UNIVERSITY   (Taiwan)

Author keywords

Defensin; Human parvovirus B19 (B19); Non structural protein (NS1); Toll like receptor (TLR); Viral protein 2 (VP2)

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN 1; BETA DEFENSIN 3; BETA DEFENSIN 5; BETA DEFENSIN 6; DEFENSIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; EPITHELIUM CELL; GENETIC TRANSFECTION; HUMAN PARVOVIRUS B19; HUMORAL IMMUNITY; INNATE IMMUNITY; NONHUMAN; OPEN READING FRAME; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 80955150887     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: 10.4077/CJP.2011.AMM060     Document Type: Article

References (49)

1. Birchler, T., Seibl, R., Büchner, K., Loeliger, S., Seger, R., Hossle, J.P., Aguzzi, A. and Lauener, R.P. Human Toll-like receptor 2 mediates induction of the antimicrobial peptide human bdefensin 2 in response to bacterial lipoprotein. Eur. J. Immunol. 31: 3131-3137, 2001.
2. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal. Biochem. 72: 248-254, 1976.
3. Broliden, K., Tolfvenstam, T. and Norbeck, O. Clinical aspects of parvovirus B19 infection. J. Intern. Med. 260: 285-304, 2006.
4. Buck, C.B., Day, P.M., Thompson, C.D., Lubkowski, J., Lu, W., Lowy, D.R. and Schiller, J.T. Human i-defensins (HNP1-3 and HD-5) block papillomavirus infection. Proc. Natl. Acad. Sci. USA 103: 1516-1521, 2006.
5. Chalifour, A., Jeannin, P., Gauchat, J.F., Blaecke, A., Malissard, M., N'Guyen, T., Thieblemont, N. and Delneste, Y. Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers a-defensin production. Blood 104: 1778-1783, 2004.
6. Cohen, B.J., Field, A.M., Mori, J., Brown, K.E., Clewley, J.P., St Amand, J. and Astell, C.R. Morphology and antigenicity of recombinant B19 parvovirus capsids expressed in transfected COS-7 cells. J. Gen. Virol. 76: 1233-1237, 1995.
7. Corcoran, A. and Doyle, S. Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. J. Med. Microbiol. 53: 459-475, 2004.
8. Cossart, Y.E., Field, A.M., Cant, B. and Widdows, D. Parvoviruslike particles in human sera. Lancet 1: 72-73, 1975.
9. Daher, K.A., Selsted, M.E. and Lehrer, R.I. Direct inactivation of viruses by human granulocyte defensins. J. Virol. 60: 1068-1074, 1986.
10. DeSmet, K. and Contreras, R. Human antimicrobial peptides: defensins, cathelicidins, and histatins. Biotechnol. Lett. 27: 1337-1347, 2005.
11. Duits, L.A., Nibbering, P.H., van Strijen, E., Vos, J.B., Mannesse-Lazeroms, S.P., van Sterkenburg, M.A. and Hiemstra, P.S. Rhinovirus increases human defensin-2 and-3 mRNA expression in cultured bronchial epithelial cells. FEMS Immunol. Med. Microbiol. 38: 59-64, 2003.
12. Fischer, M. and Ehlers, M. Toll-like receptors in autoimmunity. Ann. N. Y. Acad. Sci. 1143: 21-34, 2008.
13. Froy, O. Regulation of mammalian defensin expression by Tolllike receptor-dependent and independent signalling pathways. Cell. Microbiol. 7: 1387-1397, 2005.
14. Ganz, T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3: 710-720, 2003.
15. Gong, L., Zhang, B., Zhang, Y., Hu, H., Zhao, Z. and Liu, X. Cloning, expression and purification of human S-adenosyl methionine decarboxylase gene alpha subunit. Chinese J. Physiol. 50: 29-33, 2007.
16. Hsu, T.C., Wu, W.J., Chen, M.C. and Tsay, G.J. Human parvovirus B19 non-structural protein (NS1) induces apoptosis through mitochondria cell death pathway in COS-7 cells. Scand. J. Infect. Dis. 36: 570-577, 2004.
17. Hsu, T.C., Tzang, B.S., Huang, C.N., Lee, Y.J., Liu, G.Y., Chen, M.C. and Tsay, G.J. Increased expression and secretion of interleukin-6 in human parvovirus B19 non-structural protein (NS1) transfected COS-7 epithelial cells. Clin. Exp. Immunol. 144: 152-157, 2006.
18. Klenerman, P., Tolfvenstam, T., Price, D.A., Nixon, D.F., Broliden, K. and Oxenius, A. T lymphocyte responses against human parvovirus B19: small virus, big response. Pathol. Biol. (Paris). 50: 317-325, 2002.
19. Klotman, M. and Chang, T.L. Defensins in innate antiviral immunity. Nature Rev. Immunol. 6: 447-456, 2006.
20. Kluver, E., Adermann, K. and Schulz, A. Synthesis and structureactivity relationship of r-defensins, multi-functional peptides of the immune system. J. Pept. Sci. 12: 243-257, 2006.
21. Lehmann, H.W., von Landenberg, P. and Modrow, S. Parvovirus B19 infection and autoimmune disease. Autoimmun. Rev. 2: 218-223, 2003.
22. Li, M., Zhou, Y., Feng, G. and Su, S.B. The critical role of Toll-like receptor signaling pathways in the induction and progression of autoimmune diseases. Curr. Mol. Med. 9: 365-374, 2009.
23. Loizou, S., Cazabon, J.K., Walport, M.J., Tait, D. and So, A.K. Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus. Arthritis Rheum. 40: 103-108, 1997.
24. Mitchell, L.A. Parvovirus B19 nonstructural (NS1) protein as a transactivator of interleukin-6 synthesis: common pathway in inflammatory sequelae of human parvovirus infections? J. Med. Virol. 67: 267-274, 2002.
25. Momoeda, M., Wong, S., Kawase, M., Young, N.S. and Kajigaya, S. A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity. J. Virol. 68: 8443-8446, 1994.
26. Morita, E. and Sugamura, K. Human parvovirus B19-induced cell cycle arrest and apoptosis. Springer Semin. Immunopathol. 24: 187-199, 2002.
27. Nakashima, A., Morita, E., Saito, S. and Sugamura, K. Human Parvovirus B19 nonstructural protein transactivates the p21/WAF1 through Sp1. Virology 329: 493-504, 2004.
28. Nakashima, H., Yamamoto, N., Masuda, M. and Fujii, N. Defensins inhibit HIV replication in vitro. AIDS 7: 1129, 1993.
29. Oppenheim, J.J., Biragyn, A., Kwak, L.W. and Yang, D. Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann. Rheum. Dis. 62: 17-21, 2003.
30. Romano Carratelli, C., Mazzola, N., Paolillo, R., Sorrentino, S. and Rizzo, A. Toll-like receptor-4 (TLR4) mediates human R-defensin-2 (hBD-2) induction in response to Chlamydia pneumoniae in mononuclear cells. FEMS Immunol. Med. Microbiol. 57: 116-124, 2009.
31. Schroder, J.M. and Harder, J. Molecules in focus human 3-defensin-2, Int. J. Biochem. Cell Biol. 31: 645-651, 1999.
32. Selsted, M. and Ouellette, A.J. Mammalian defensins in the Antimicrobial immune response. Nat. Immunol. 6: 551-557, 2005.
33. Takeda, K. and Akira, S. Toll-like receptors. Curr. Protoc. Immunol. Chapter 14:Unit 14.12, 2007.
34. + T cells independently of CCR6. Eur. J. Immunol. 39: 1353-1360, 2009.
35. Tzang, B.S., Chen, D.Y., Tsai, C.C., Chiang, S.Y., Lin, T.M. and Hsu, T.C. Human parvovirus B19 nonstructural protein NS1 enhanced the expression of cleavage of 70kDa U1-snRNP autoantigen. J. Biomed. Sci. 17: 40, 2010.
36. Tzang, B.S., Lee, Y.J., Yang, T.P., Tsay, G.J., Shi, J.U., Tsai, C.C. and Hsu, T.C. Induction of antiphospholipid antibodies and antiphospholipid syndrome-like autoimmunity in naive mice with antibody against human Parvovirus B19 VP1 unique region protein. Clin. Chim. Acta 382: 31-36, 2007.
37. Tzang, B.S., Tsai, C.C., Chiu, C.C., Shi, J.U. and Hsu, T.C. Upregulation of adhesion molecule expression and induction of TNF-ooon vascular endothelial cells by antibody against human parvovirus B19 VP1 unique tegion protein. Clin. Chim. Acta 395: 77-83, 2008.
38. Tzang, B.S., Tsai, C.C., Tsay, G.J., Wang, M., Sun, Y.S. and Hsu, T.C. Anti-human parvovirus B19 non-structural protein antibodies in patients with rheumatoid arthritis. Clin. Chim. Acta 405: 76-82, 2009.
39. Tzang, B.S., Tsay, G.J., Lee, Y.J., Li, C., Sun, Y.S. and Hsu, T.C. The association of VP1 unique region protein in acute parvovirus B19 infection and antiphospholipid antibody production. Clin. Chim. Acta 378: 59-65, 2007.
40. Vongsa, R.A., Zimmerman, N.P. and Dwinell, M.B. CCR6 regulation of the actin cytoskeleton orchestrates human beta defensin-2-and CCL20-mediated restitution of colonic epithelial cells. J. Biol. Chem. 284: 10034-10045, 2009.
41. Wang, H.P., Hsu, T.C., Hsu, G.J., Li, S.L. and Tzang, B.S. Cystamine attenuates the expressions of NOS-and TLR-associated molecules in brain of NZB/W F1 mice. Eur. J. Pharmacol. 607: 102-106, 2009.
42. Wang, W., Zhu, G.J. and Zu, S.Y. Effects of 174-estradiol and phytoestrogen p-zearalanol on tissue factor in plasma of ovariectomized rats and HUVECs. Chinese J. Physiol. 47: 67-72, 2004.
43. Yan, C.G., Ren, G.Y., Wang, F., Zhu, D.F. and Zhuang, Y. CD14-159 and-260 gene polymorphisms are associated with HBV-related cirrhotic injury in Chinese Han patients. Chinese J. Physiol. 51: 94-99, 2008.
44. Yang, D., Biragyn, A., Kwak, L.W. and Oppenheim, J.J. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol. 23: 291-296, 2002.
45. Yang, D., Chertov, O., Bykovskaia, S.N., Chen, Q., Buffo, M.J., Shogan, J., Anderson, M., Schröder, J.M., Wang, J.M., Howard, O.M. and Oppenheim, J.J. O-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286: 525-528, 1999.
46. Yang, D., Liu, Z.H., Tewary, P., Chen, Q., de la Rosa, G. and Oppenheim, J.J. Defensin participation in innate and adaptive immunity. Curr. Pharm. Des. 13: 3131-3139, 2007.
47. Yeh, J.Y., Yen, M.S., Lo, W.Y., Chao, K.C., Yuan, C.C. and Juang, C.M. Physiology and potential application of NKT cells: a minireview. Chinese J. Physiol. 52: 275-279, 2009.
48. Young, N.S. and Brown, K.E. Parvovirus B19. N. Engl. J. Med. 350: 586-597, 2004.
49. Zhang, L., Yu, W., He, T., Yu, J., Caffrey, R.E., Dalmasso, E.A., Fu, S., Pham, T., Mei, J., Ho, J.J., Zhang, W., Lopez, P. and Ho, D.D. Contribution of human C-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 298: 995-1000, 2002.